Myriad Genetics (MYGN) Stock Forecast, Price Target & Predictions
MYGN Stock Forecast
Myriad Genetics stock forecast is as follows: an average price target of $30.20 (represents a 126.05% upside from MYGN’s last price of $13.36) and a rating consensus of 'Hold', based on 13 wall street analysts offering a 1-year stock forecast.
MYGN Price Target
MYGN Analyst Ratings
Hold
Myriad Genetics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 09, 2024 | Puneet Souda | Leerink Partners | $21.00 | $15.15 | 38.61% | 57.19% |
Oct 14, 2024 | Sung Ji Nam | Scotiabank | $34.00 | $24.67 | 37.82% | 154.49% |
Sep 19, 2024 | Tejas Savant | Morgan Stanley | $32.00 | $28.47 | 12.40% | 139.52% |
Aug 27, 2024 | Brandon Couillard | Wells Fargo | $35.00 | $27.50 | 27.27% | 161.98% |
Aug 07, 2024 | Subbu Nambi | Guggenheim | $29.00 | $25.96 | 11.71% | 117.07% |
Jun 26, 2024 | Sung Ji Nam | Scotiabank | $29.00 | $24.62 | 17.79% | 117.07% |
May 13, 2024 | Jon Peterson | Piper Sandler | $28.00 | $25.07 | 11.69% | 109.58% |
Dec 21, 2023 | David Westenberg | Piper Sandler | $23.00 | $20.49 | 12.25% | 72.16% |
Oct 05, 2022 | Mason Carrico | Stephens | $22.00 | $20.82 | 5.67% | 64.67% |
Apr 19, 2022 | Goldman Sachs | $23.00 | $23.03 | -0.13% | 72.16% |
Myriad Genetics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 3 | 8 |
Avg Price Target | $21.00 | $29.00 | $28.88 |
Last Closing Price | $13.36 | $13.36 | $13.36 |
Upside/Downside | 57.19% | 117.07% | 116.17% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 09, 2024 | Leerink Partners | Outperform | Market Perform | Downgrade |
Oct 14, 2024 | Scotiabank | Sector Outperform | Sector Outperform | Hold |
Sep 19, 2024 | Morgan Stanley | Equal-Weight | Initialise | |
Aug 27, 2024 | Wells Fargo | Overweight | Initialise | |
Aug 13, 2024 | Scotiabank | Outperform | Outperform | Hold |
Aug 13, 2024 | Piper Sandler | Neutral | Neutral | Hold |
Aug 07, 2024 | Cowen & Co. | Hold | Hold | Hold |
Aug 07, 2024 | Guggenheim | Buy | Buy | Hold |
Jun 26, 2024 | Scotiabank | Outperform | Sector Outperform | Initialise |
Jun 26, 2024 | Scotiabank | Outperform | Initialise | |
Jun 03, 2024 | Jefferies | Underperform | Downgrade | |
May 13, 2024 | Piper Sandler | Neutral | Neutral | Hold |
May 08, 2024 | Leerink Partners | Outperform | Upgrade | |
May 23, 2023 | SVB Leerink | Market Perform | Downgrade | |
May 23, 2023 | Citigroup | Neutral | Downgrade | |
May 23, 2023 | Keefe, Bruyette & Woods | Market Perform | Upgrade | |
May 23, 2023 | Goldman Sachs | Buy | Upgrade | |
May 23, 2023 | EF Hutton | Hold | Downgrade | |
May 23, 2023 | Credit Suisse | Neutral | Downgrade | |
Oct 06, 2022 | Stephens | Equal-Weight | Initialise |
Myriad Genetics Financial Forecast
Myriad Genetics Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $191.90M | - | $181.20M | $177.80M | $156.40M | $179.30M | $164.90M | $160.80M | $167.30M | $189.40M | $173.10M | $154.60M | $145.20M | $93.20M | $164.00M | $195.10M | $186.30M |
Avg Forecast | $247.72M | $240.12M | $240.91M | $232.13M | $226.30M | $219.55M | $220.21M | $212.42M | $213.31M | $210.76M | $206.44M | $193.51M | $194.80M | $182.32M | $187.16M | $171.49M | $169.47M | $170.07M | $170.96M | $156.67M | $162.96M | $165.04M | $162.54M | $154.42M | $93.89M | $167.38M | $209.66M | $202.32M | $221.64M | $217.77M |
High Forecast | $254.37M | $246.56M | $247.37M | $238.35M | $232.37M | $225.44M | $226.11M | $220.22M | $217.47M | $210.85M | $206.44M | $193.63M | $195.47M | $183.87M | $192.18M | $176.10M | $174.02M | $170.07M | $170.96M | $156.67M | $162.96M | $165.04M | $162.54M | $154.42M | $93.89M | $167.38M | $209.66M | $202.32M | $221.64M | $217.77M |
Low Forecast | $241.95M | $234.52M | $235.30M | $226.72M | $221.03M | $214.44M | $215.08M | $205.64M | $210.12M | $210.66M | $206.44M | $193.38M | $193.36M | $180.77M | $182.80M | $167.50M | $165.53M | $170.07M | $170.96M | $156.67M | $162.96M | $165.04M | $162.54M | $154.42M | $93.89M | $167.38M | $209.66M | $202.32M | $221.64M | $217.77M |
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 10 | 9 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | - | 1.06% | 1.05% | 0.92% | 1.05% | 1.05% | 0.99% | 1.01% | 1.17% | 1.12% | 1.65% | 0.87% | 0.44% | 0.81% | 0.88% | 0.86% |
Forecast
Myriad Genetics EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 10 | 9 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-46.10M | $-297.20M | $-32.70M | $-31.30M | $-30.30M | $-4.40M | $-1.80M | $-29.70M | $55.10M | $15.10M | $-28.20M | $-34.70M | $-23.10M | $-37.60M | $-110.90M | $9.30M | $-1.20M |
Avg Forecast | $-22.15M | $-21.47M | $-21.54M | $-20.75M | $-20.23M | $-19.63M | $-19.69M | $-18.99M | $-19.07M | $-18.84M | $-18.45M | $-21.39M | $-17.41M | $-16.30M | $-16.73M | $-19.45M | $-32.67M | $-3.36M | $-3.38M | $-17.68M | $-3.22M | $-3.26M | $-3.21M | $-39.88M | $-1.85M | $-3.31M | $-4.14M | $-998.10M | $-4.38M | $-4.30M |
High Forecast | $-21.63M | $-20.97M | $-21.03M | $-20.27M | $-19.76M | $-19.17M | $-19.23M | $-18.38M | $-18.78M | $-18.83M | $-18.45M | $-17.11M | $-17.29M | $-16.16M | $-16.34M | $-15.56M | $-26.14M | $-3.36M | $-3.38M | $-14.14M | $-3.22M | $-3.26M | $-3.21M | $-31.91M | $-1.85M | $-3.31M | $-4.14M | $-798.48M | $-4.38M | $-4.30M |
Low Forecast | $-22.74M | $-22.04M | $-22.11M | $-21.31M | $-20.77M | $-20.15M | $-20.21M | $-19.69M | $-19.44M | $-18.85M | $-18.45M | $-25.67M | $-17.47M | $-16.44M | $-17.18M | $-23.34M | $-39.20M | $-3.36M | $-3.38M | $-21.21M | $-3.22M | $-3.26M | $-3.21M | $-47.86M | $-1.85M | $-3.31M | $-4.14M | $-1.20B | $-4.38M | $-4.30M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.83% | 17.76% | 1.68% | 0.96% | 9.02% | 1.30% | 0.10% | 9.23% | -16.91% | -4.70% | 0.71% | 18.71% | 6.99% | 9.08% | 0.11% | -2.12% | 0.28% |
Forecast
Myriad Genetics Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 10 | 9 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-61.30M | $-116.10M | $-54.70M | $-42.30M | $-35.10M | $-14.10M | $-20.50M | $-7.60M | $24.60M | $-4.70M | $-39.50M | $-44.20M | $-15.20M | $-55.40M | $-115.20M | $-8.30M | $-20.60M |
Avg Forecast | $8.95M | $6.93M | $7.70M | $5.54M | $4.88M | $2.98M | $1.69M | $-254.97K | $2.38M | $1.70M | $-1.06M | $-35.08M | $1.29M | $-6.87M | $-7.37M | $-31.89M | $-8.36M | $-3.28M | $2.05M | $-28.99M | $-1.94M | $-1.46M | $-8.28M | $-55.86M | $-38.13M | $614.25K | $25.08M | $-1.04B | $38.19M | $35.51M |
High Forecast | $9.26M | $7.18M | $7.96M | $5.74M | $5.05M | $3.08M | $1.75M | $1.02M | $2.46M | $1.74M | $-1.03M | $-28.07M | $1.33M | $-6.66M | $-7.15M | $-25.51M | $-6.69M | $-3.28M | $2.05M | $-23.19M | $-1.94M | $-1.46M | $-8.28M | $-44.69M | $-38.13M | $614.25K | $25.08M | $-829.44M | $38.19M | $35.51M |
Low Forecast | $8.67M | $6.72M | $7.46M | $5.38M | $4.74M | $2.89M | $1.64M | $-1.53M | $1.59M | $1.67M | $-1.10M | $-42.10M | $643.89K | $-7.11M | $-7.63M | $-38.27M | $-10.03M | $-3.28M | $2.05M | $-34.79M | $-1.94M | $-1.46M | $-8.28M | $-67.04M | $-38.13M | $614.25K | $25.08M | $-1.24B | $38.19M | $35.51M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.93% | 15.75% | 1.72% | 5.06% | 10.71% | -6.89% | 0.71% | 3.91% | -16.90% | 0.57% | 0.71% | 1.16% | -24.75% | -2.21% | 0.11% | -0.22% | -0.58% |
Forecast
Myriad Genetics SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 10 | 9 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $170.40M | $140.70M | $151.70M | $146.50M | $130.50M | $127.10M | $110.60M | $139.30M | $180.20M | $134.80M | $145.50M | $132.90M | $124.10M | $107.40M | $132.90M | $135.60M | $135.50M |
Avg Forecast | $195.18M | $189.19M | $189.81M | $182.89M | $178.30M | $172.98M | $173.50M | $167.37M | $168.07M | $166.05M | $162.65M | $189.27M | $153.48M | $143.65M | $147.46M | $135.12M | $85.03M | $130.32M | $131.00M | $156.42M | $124.88M | $126.47M | $124.56M | $118.33M | $71.95M | $128.27M | $160.67M | $155.03M | $169.84M | $166.88M |
High Forecast | $200.41M | $194.26M | $194.90M | $187.80M | $183.08M | $177.63M | $178.15M | $173.51M | $171.34M | $166.13M | $162.65M | $227.12M | $154.01M | $144.87M | $151.41M | $138.74M | $102.04M | $130.32M | $131.00M | $187.70M | $124.88M | $126.47M | $124.56M | $118.33M | $71.95M | $128.27M | $160.67M | $155.03M | $169.84M | $166.88M |
Low Forecast | $190.63M | $184.78M | $185.39M | $178.63M | $174.14M | $168.95M | $169.46M | $162.02M | $165.55M | $165.98M | $162.65M | $151.41M | $152.34M | $142.43M | $144.02M | $131.97M | $68.02M | $130.32M | $131.00M | $125.14M | $124.88M | $126.47M | $124.56M | $118.33M | $71.95M | $128.27M | $160.67M | $155.03M | $169.84M | $166.88M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.19% | 0.95% | 1.12% | 1.72% | 1.00% | 0.97% | 0.71% | 1.12% | 1.42% | 1.08% | 1.23% | 1.85% | 0.97% | 0.67% | 0.86% | 0.80% | 0.81% |
Forecast
Myriad Genetics EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 10 | 9 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.75 | $-1.42 | $-0.67 | $-0.52 | $-0.43 | $-0.18 | $-0.26 | $-0.10 | $0.31 | $-0.06 | $-0.52 | $-0.59 | $-0.20 | $-0.74 | $-1.55 | $-0.11 | $-0.28 |
Avg Forecast | $0.10 | $0.08 | $0.08 | $0.06 | $0.05 | $0.03 | $0.02 | $-0.00 | $0.03 | $0.02 | $-0.01 | $-0.10 | $0.01 | $-0.08 | $-0.08 | $-0.19 | $-0.16 | $-0.04 | $0.03 | $-0.08 | $-0.02 | $-0.02 | $-0.10 | $-0.15 | $-0.47 | $0.01 | $0.31 | $0.31 | $0.47 | $0.43 |
High Forecast | $0.10 | $0.08 | $0.09 | $0.06 | $0.06 | $0.03 | $0.02 | $0.01 | $0.03 | $0.02 | $-0.01 | $-0.10 | $0.01 | $-0.07 | $-0.08 | $-0.19 | $-0.16 | $-0.04 | $0.03 | $-0.08 | $-0.02 | $-0.02 | $-0.10 | $-0.15 | $-0.47 | $0.01 | $0.31 | $0.31 | $0.47 | $0.43 |
Low Forecast | $0.10 | $0.07 | $0.08 | $0.06 | $0.05 | $0.03 | $0.02 | $-0.02 | $0.02 | $0.02 | $-0.01 | $-0.11 | $0.01 | $-0.08 | $-0.08 | $-0.20 | $-0.17 | $-0.04 | $0.03 | $-0.08 | $-0.02 | $-0.02 | $-0.10 | $-0.15 | $-0.47 | $0.01 | $0.31 | $0.31 | $0.47 | $0.43 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.93% | 17.51% | 3.47% | 3.18% | 10.75% | -7.20% | 3.13% | 4.01% | -17.44% | 0.59% | 3.44% | 1.27% | -26.67% | -2.42% | -4.93% | -0.24% | -0.65% |
Forecast
Myriad Genetics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
MYGN | Myriad Genetics | $13.82 | $30.20 | 118.52% | Hold |
PSNL | Personalis | $3.84 | $7.38 | 92.19% | Hold |
ACRS | Aclaris Therapeutics | $3.26 | $6.00 | 84.05% | Buy |
CDNA | CareDx | $22.14 | $37.50 | 69.38% | Buy |
NEOG | Neogen | $12.13 | $17.50 | 44.27% | Buy |
CSTL | Castle Biosciences | $28.14 | $40.50 | 43.92% | Buy |
EXAS | Exact Sciences | $60.37 | $77.43 | 28.26% | Buy |
SHC | Sotera Health Company | $13.08 | $16.00 | 22.32% | Buy |
RDNT | RadNet | $76.52 | $91.00 | 18.92% | Buy |
GH | Guardant Health | $34.84 | $40.60 | 16.53% | Buy |
QGEN | Qiagen | $45.34 | $48.33 | 6.59% | Buy |
MEDP | Medpace | $348.48 | $369.67 | 6.08% | Hold |
ILMN | Illumina | $143.12 | $147.78 | 3.26% | Buy |
TWST | Twist Bioscience | $48.40 | $46.00 | -4.96% | Buy |
NTRA | Natera | $168.21 | $151.50 | -9.93% | Buy |